Readmissions and adverse drug reactions in internal medicine: the economic impact. - Dormann, H.; Neubert, A.; Criegee-Rieck, M.; Egger, T.; Radespiel-Tröger, M.; Azaz-Livshits, T.; Levy, M.; Brune, K.; Hahn, E.G. (Journal of Internal Medicine, 2004)